Reliq Health Technologies Inc V.RHT.H

RE:RE:RE:Valuation

[eljoro]

Why are we still undervalued??

Because we are an upstart company with a disruptive technology trading on the Venture with a share price that only in recent months traded above $1. Many funds can't even consider buying our shares based on valuation and where we trade. This is why I am so supportive of the company goal of trading on the NASDAQ.

Because we are not a pot, cryptocurrency or blockchain company. Sometimes it doesn't pay in the short term to not be flavour of the minute.

Because we are still ramping up and only today announced that we are profitable.Some investors want to see quarterly numbers that reflect profitability.

Because sometimes people just can't believe in a near-sure thing investment story and want to trade for pennies when they could INVEST and make dollars.

I was lucky enough to learn about this company when it was .12-.14 and I hemmed and hawed for a week while I tried to gauge what about this company was different.  Some great posts by people like mingzhu helped me understand the potential. I finally started buying around .17 and have added as recently as today. I now own 75K shares and will buy up to 100K if I can free up additional monies. I even added 5K additional shares @ .29 into my 10 month old's RESP...that has proved to be a good move and I expect that RHT will help pay a decent chunk of his education down the road.

Almost everything that the CEO has projected has happened, and has explained why some things (ie Feldman, NHS) have been slower to finalize than originally expected. Every timeline for the onboaring of Texas patients has been met. Some additional contract surprises have come out way and an increasing number of public portfolio managers (ie. Bruce Campbell, Peter Imhof) have taken positions and started telling Reliq's story.

And most important of all: There are still MILLIONS of potential patients this technology can directly benefit all while reducing costs for health care providers and government. Even if Reliq captures 5% of the potential # of applicable patients in the US only we will see our share price trading multiple times higher. There is always the potential for a takeout too, if the Apples and Googles of the world decide to get into telehealth in a big way.

I need a glass of water. I'm starting to froth at the mouth.
Best,
El Joro